Page 1430 - Problem-Based Feline Medicine
P. 1430

INDEX  1423


           Demodex cati, 1048               differential diagnosis, 1323  inflammatory bowel disease, 673
           Demodicosis, 1045, 1047–1048,    eyelid, 1318, 1322–1323       laryngitis, 102
               1061                         pathogenesis, 1060           Dexamethasone suppression test, 251,
             alopecia, 1054, 1061           treatment, 1323                 258, 325
             peri-ocular, 1327, 1365      Derm caps, 1365                Dexrazoxane, 1365
             pruritus, 1047–1048          Dermis wounds, non-healing, 1085  Dextran, 559, 1366
           Dendritic (branching) epithelial  Dermoid cysts, 806          Dextroamfetamine, 1366
               lesions, 1238              Descemetocele, 1236, 1244      Dextromethorphan, 1366
           Dental caries, 28                ulcerative keratitis, 1246, 1247  Dextroposition of the aorta, 149
           Dental disease                 Descemet’s membrane, 1236, 1262  Dextrose, 1366
             clinical signs, 354          Desensitization                 acute renal failure and, 282
             infertility, male/tom, 1150    fear aggression, 1000         hyperkalemia treatment, 282
             orbital inflammation, 1211     pain aggression, 1005         hypoadrenocorticism, 755
             rhinitis, secondary, 20, 27–28  redirected aggression, 997   hypoglycemia, 296–297, 957
           Dental fracture with periapical  status-related aggression, 1002–1003  kittens/neonates, 1133
               abscessation, 603, 610       to stroking, 1002             urethral obstruction, 181
           Dental management, oral inflammatory  Desferoxamine mesylate, 824  Diabetes insipidus, 232, 243–244
               disease, 354–355           Desmopressin acetate, 1365      central, 243
           Dental mirrors                 Detemir, 238                    nephrogenic, 243
             foreign body identification, 28  Detrusor atonic bladder see  polyuria/polydipsia, 243–244
             nasopharyngeal polyps diagnosis, 30  Hypocontractile bladder   prevention, 241
           Dental prophylaxis, 605, 606   Detrusor atony, 194            Diabetes mellitus, 231, 236–242,
           Dental radiography, retrobulbar  Detrusor muscle, 175, 195       310–313, 355–356, 436, 574–575,
               infection, 1232              dysfunction, 195–196            681–682, 1059–1060, 1122
           Deoxycorticosterone acetate, 1365,  Detrusor-urethral dyssynergia, 198  alopecia, 1053, 1059–1060
               1365                       Devon Rex                       clinical signs, 237, 243, 302, 310,
           Deoxycorticosterone pivalate, 1365  hypotrichosis, 1056            311, 331, 355, 574–575, 681,
           Deprenyl, 1365                   vitamin K responsive coagulopathy,  1059, 1122
           Depression                          484, 515–516               diagnosis, 237, 311–312, 355–356,
             acute, 261–300               Devon Rex myopathy, 626–627,        575, 681, 1059–1060, 1122
               causes/diseases causing, 266–299  900–901                  dietary modification, 312
               clinical signs, 265          clinical signs, 614, 627, 900–901, 965  differential diagnosis, 237, 312, 681
               mechanisms of, 265           diagnosis, 627, 901, 965      hyperlipidemia in, 570, 574–575
             definition, 265                differential diagnosis, 627, 901  jaundice/elevated liver enzymes,
             thiamine deficiency, 808       neck ventroflexion, 890, 900–901  422, 436
           L-depronyl, 252, 326             pathogenesis, 626, 900        pathogenesis, 236, 310–311, 574
           Dermacentor ticks, 944, 953      prevention, 627, 901          paw/pad problems, 1108, 1122
           Dermacentor variabilis, 535      prognosis, 627, 901, 965      polyuria/polydipsia, 224, 236–242
           Dermal atrophy, 1098             regurgitation, 626–627        poorly controlled, 255
           Dermatitis see specific          treatment, 627, 901           prevention, 242, 313
               diseases/disorders           weakness, generalized, 942    prognosis, 241, 313
           Dermatophytes, 1032–1034       Dexamethasone, 1365             remission, 240–241, 831
             clinical signs, 1033           asthma, 95                    risk factors, 236
             differential diagnosis, 1033   asthma/bronchitis complex, 53–54  thin, inappetent, 355–356
             infectious pododermatitis, 1111  autoimmune dermatoses, 1043  transient, 238
             miliary dermatitis, 1023, 1032–1034  eosinophilic keratoconjunctivitis,  treatment, 237–241, 312–313, 575,
             pathogenesis, 1032–1033           1221                           681–682
             treatment, 1033–1034           esophagitis, 592                healthy cat, 239–240
           Dermatophytosis, 1060–1061,      household cleaner/disinfectant  type 1, 310
               1322–1323                       ingestion, 588             type 2, 310–311
             alopecia, 1054, 1060–1061      hydrocephalus, 828              acromegaly, 322, 323
             clinical signs, 1060, 1322     immune-mediated hemolytic     type 3/secondary, 311
             diagnosis, 1060–1061, 1323        anemia, 533                vomiting, acute, 631
   1425   1426   1427   1428   1429   1430   1431   1432   1433   1434   1435